BioProgress
This article was originally published in The Rose Sheet
Executive Summary
XGel gelatine-free capsule marketer signs agreement with Nottingham, England-based Boots Healthcare, companies announce Oct. 20. Boots firm will use Atlanta-based BioProgress' animal-free, one-piece soft capsule technology under terms of the deal. Partnership marks BioProgress' second with a British firm, following a summer agreement with Peter Black Healthcare. BioProgress also developing environmentally friendly material for sanitary napkins and diapers, company says. Boots' U.S. subsidiary recently acquired the Clearasil anti-acne line from Procter & Gamble (1"The Rose Sheet" Oct. 23, p. 3)